Invasive BCI Solutions, Growing Medical End-Use Adoption, and Rising Government Focus on Neurotechnology Propel Market Expansion.Austin, United States, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Brain Computer ...

Paradromics announced today that it kicked off a new partnership program to open collaboration on brain-computer interface ...

Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market The Company stated that these ...

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and ...

China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...

China could see brain-computer interface (BCI) technology move into practical public use within three to five years as products mature, a leading BCI expert ...

Brain-computer interface technology has long belonged to the realm of science fiction, but it’s quickly emerging as a real-world innovation with the potential to transform how we live, work and ...

BOSTON--(BUSINESS WIRE)--Neurable Inc., the neurotechnology company democratizing BCI technology, announced today that it has raised an additional $13 million in funding from Ultratech Capital ...

Cognixion, a developer of noninvasive brain-computer interface (BCI) technology, announced that Blackrock Neurotech, a company that makes implantable BCIs, will provide Cognixion's Axon-R wearable ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and memory impairment with an insidious and irreversible pathological process. As ...

Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...